Moderna has lowered the high end of its 2025 revenue forecast, citing a delay in Covid vaccine shipments to the UK. The company now expects between $1.5 billion and $2.2 billion in revenue, down $300 million at the top of its earlier range. The adjustment comes as Moderna continues to…
Brazil’s antitrust regulator CADE has opened an investigation into US tech giant Microsoft at the request of Norwegian browser…
Reddit Inc. shares surged on Friday after the company posted its most profitable quarter to date and offered a…
OpenAI has secured $8.3 billion in new capital as part of its ongoing $40 billion fundraising effort, CNBC reported,…
Novo Nordisk stock sharply tanked this week, marking the pharmaceutical company’s worst-ever weekly loss with a decline of more…
Private equity-backed insurers are intensifying their presence in the UK’s booming pension risk-transfer market, securing deals worth $10.7 billion…
US stocks kicked off August with a sharp retreat as the Trump administration announced reciprocal tariffs on several countries…
Nio Inc (NYSE: NIO) rallied about 10% late on Thursday following news that its sub-brand Onvo saw its newly…